Neurogait

Developer of an AI platform for neurological disease diagnosis and monitoring.

Health Tech & Life Sciences
Active
Seed Ra'anana, Israel Founded 2019
Last updated 2026-07-20
Total raised
Last: Undisclosed Round 2019-07
Stage
Seed
Founded
2019
Headcount
3
HQ
Ra'anana, Israel
Sector
Health Tech & Life Sciences

About

Neurogait is an Israeli startup developing an AI platform for neurological disease diagnosis and monitoring. The platform utilizes machine learning and neural networks to track neurological symptoms using sensor data, providing neurologists with patient symptom data to optimize medication protocols in real-time. The system also aims to improve patients' daily quality of life through an autonomous mode. Neurogait's solution includes a fast, smartphone-based gait screening test that uses computer vision to quantify spatiotemporal gait features and a validated machine-learning model to flag patterns consistent with Normal Pressure Hydrocephalus (NPH). Neurogait is currently conducting clinical pilots in Germany and is integrating its solution under a commercial agreement with a large online European patient platform. It is also working on its regulatory approvals.

Funding history · 1 round · — total

2019-06
Seed Undisclosed

Headcount over time

From 2 (2020-07) to 3 (2025-10) · +1 (+50%) · 9 points · source: Finder history + radar grounding
40 2020-07 2025-10

Q&A

What is Neurogait's primary focus?
Neurogait is developing AI-based clinical screenings for neurodegenerative diseases, including curable dementia and Parkinson's.
Where is Neurogait currently conducting clinical pilots?
Neurogait is currently conducting clinical pilots in Germany.
What is Neurogait's current commercial activity?
Neurogait is integrating its solution under a commercial agreement with a large online European patient platform.
When was Neurogait founded?
Neurogait was founded in July 2019.
Who are the co-founders of Neurogait?
The co-founders of Neurogait are Eyal Fruchtman, who also serves as CEO, and Ben Francke.
What technologies does Neurogait utilize?
Neurogait utilizes Artificial Intelligence, Deep Learning, Computer Vision, Machine Learning, and Sensing technologies.
What is Neurogait's current product stage?
Neurogait's product is currently in beta stage.

Team · 2

Eyal Fruchtman
Founder · CEO Co-Founder
Ben Francke
Founder · Co-founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesDigital HealthcareDigital Medical Diagnostics
Technologies
SensingArtificial IntelligenceDeep LearningComputer VisionMachine Learning
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsMedical Devices Industry
Business model
B2B2CB2B

Highlights

Verified

Tags

deep-learningneurosciencedigital-healthcaremachine-learningneurologyartificial-intelligencealzheimers-diseasecomputer-visionparkinsonhome-caremedical-technologiesmachine-visiondiagnosticssensorsearly-detectionmedical-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteneurogait.com/
LinkedInlinkedin.com/company/37436801

Identifiers & details

Founded2019-7
Employees (exact)3

Radar intelligence

Web history (Wayback)

Domainneurogait.com

Certificate / subdomain footprint

Subdomains6

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516062767
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2019-07-29
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens1
Registry events3 — charge (1), violation (1), annual_report (1)
Registered addressחצב 167 בני ציון

Recent registry events

DateEvent
2025-10-29רישום שעבוד
2025-10-28עדכון הפרה
2025-10-28דו~ח שנתי